Brussels, 12/09/2000 (Agence Europe) - Following its rapoprteur, Ms Anneli Hulthén (PES, Sweden), the European Parliament unanimously endorsed, without amendments, revision of the Community regulation on substances that impoverish the ozone layer, in order to explicitly authorise the export by the Union of inhaler sprays and medical pumps, containing CFCs, for the administering of medicines, to developing countries. The amended regulation raises ambiguity due to the inconsistencies in the text of the initial regulation, which mistakenly led one to believe that the export of these products towards LDCs was banned although the EU had never had the intention to deprive these countries of products they need for public health purposes. This ambiguity had given rise to problems during the implementation of the regulation even though exports of such products for therapeutic purposes is in no way in contradiction with the obligations resulting from the Montreal Protocol.